SCHEMBL2722838

SCHEMBL2722838

CN1CCC(NC(c2cccc(I)c2)c2nc3ccccc3[nH]2)CC1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ HRH4 Q9H3N8 3/20 0.40
▸ VCP P55072 3/20 0.37
▸ HTR3A P46098 1/20 0.36
▸ LMNA P02545 2/20 0.36
▸ TSHR P16473 1/20 0.36
▸ IDO1 P14902 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ MLKL Q8NB16 3/20 0.35
▸ TRPC3 Q13507 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ ALOX12 P18054 1/20 0.34
▸ ALPL P05186 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ KCNH2 Q12809 1/20 0.34
▸ BCHE P06276 1/20 0.34
▸ ACHE P22303 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2722467 0.89 MLKL (0.43) HRH4VCPHTR3ALMNATSHR
SCHEMBL900372 0.89 ALPL (0.41) HRH4VCPHTR3ALMNATSHR
SCHEMBL2720358 0.88 HRH4 (0.45) HRH4VCPHTR3ALMNATSHR
SCHEMBL2720674 0.88 HRH4 (0.40) HRH4VCPHTR3ALMNATSHR
SCHEMBL899828 0.88 HRH4 (0.42) HRH4VCPHTR3ALMNATSHR
SCHEMBL2723739 0.88 VCP (0.40) HRH4VCPHTR3AKMT2AALPL
SCHEMBL2722093 0.88 KMT2A (0.41) HRH4VCPHTR3ALMNATSHR
SCHEMBL2720491 0.86 HRH4 (0.39) HRH4VCPHTR3ALMNATSHR
SCHEMBL2721609 0.86 HRH4 (0.39) HRH4VCPHTR3ALMNATSHR
SCHEMBL2720352 0.86 ALDH1A1 (0.44) HRH4ALDH1A1POLBSMN1; SMN2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2621916-B1 BENZAZOLE DERIVATIVES AS HISTAMINE H4 RECEPTOR LIGANDS BIOPROJET SOC CIV (FR) 2016-02-10 — — EP disclosed
US-9029357-B2 Benzazole derivatives as histamine H4 receptor ligands BIOPROJET (FR) 2015-05-12 — — US disclosed
US-20150004181-A1 Benzazole Derivatives as Histamine H4 Receptor Ligands BIOPROJET SOC CIV (FR) 2015-01-01 — — US disclosed
US-8802664-B2 Benzazole derivatives as histamine H4 receptor ligands BIOPROJECT (FR) 2014-08-12 — — US disclosed
US-20130231329-A1 Benzazole Derivatives as Histamine H4 Receptor Ligands BIOPROJET (FR) 2013-09-05 — — US disclosed
EP-2621916-A1 BENZAZOLE DERIVATIVES AS HISTAMINE H4 RECEPTOR LIGANDS BIOPROJET (FR) 2013-08-07 — — EP disclosed
EP-2447263-A1 Benzazole derivatives as histamine H4 receptor ligands BIOPROJET (FR) 2012-05-02 — — EP disclosed
WO-2012041860-A1 BENZAZOLE DERIVATIVES AS HISTAMINE H4 RECEPTOR LIGANDS BIOPROJET (FR) 2012-04-05 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150004181-A1 Benzazole Derivatives as Histamine H4 Receptor Ligands HRH4, HRH3, HRH2 HRH4 1/4885VCP 2690/4885HTR3A 29/4885
US-20130231329-A1 Benzazole Derivatives as Histamine H4 Receptor Ligands HRH4, HRH3, HRH2 HRH4 1/4885VCP 3553/4885HTR3A 34/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback